Targeting shared immune pathways in multiple sclerosis and type 1 diabetes: Therapeutic insights from monoclonal antibodies
{{output}}
Multiple sclerosis (MS) and type 1 diabetes (T1D) are immune-mediated diseases that affect distinct target organs but display overlapping immunopathogenic mechanisms, including T- and B-cell dysregulation, common genetic susceptibility, and partially convergen... ...
